Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 28, 2014
Patent Application Number
12810743
Date Filed
December 23, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to methods of killing cancer cells, the methods comprising administering at least one C35 antibody and either at least one HER2 or at least one EGFR antibody. In some embodiments, the antibodies are administered with a therapeutic agent. The present invention is further directed to C35, HER2 and EGFR antibodies useful in these methods.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
